The Effect of Betulinic Acid on $TNF-{\alpha}-induced$ MCP-1 Expression in HL-60 Cells

HL-60 세포에서 $TNF-{\alpha}$에 의한 MCP-1 발현에 미치는 Betulinic Acid의 효과

  • Kim, Kyung-Chan (Department of Internal Medicine, College of Medicine, Catholic University of Daegu) ;
  • Lee, Chu-Hee (Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University)
  • 김경찬 (대구가톨릭대학교 의과대학) ;
  • 이추희 (영남대학교 의과대학)
  • Published : 2008.02.29

Abstract

Betulinic acid, a naturally occurring pentacyclic triterpenoid, is found in abundance in the outer bark of white birch (Betula alba). In this study, we investigated if betulinic acid affects cytokine expression from activated macrophage cells. ELISA result showed that stimulation of HL-60 cells with proinflammatory cytokine such as $TNF-{\alpha}$ resulted in MCP-1 release into culture medium. In addition, transcriptional upregulation of MCP-1 in response to $TNF-{\alpha}$ was observed by RT-PCR analysis. However, incubation of HL-60 cells with betulinic acid prior to $TNF-{\alpha}$ treatment abrogated MCP-1 expression in transcription and translational level. Consistent with a number of studies which reported requirement of ERK activation for $TNF-{\alpha}$ expression, Western blot analysis showed that $TNF-{\alpha}-induced$ ERK activation was suppressed by pretreatment of HL-60 cells with betulinic acid. Taken together, our data indicate that betulinic acid exerts its anti-inflammatory effect through inhibition of $TNF-{\alpha}-induced$ ERK activation which is required for the subsequent MCP-1 release.

Keywords

References

  1. Pisha, E., Chai, H., Lee, I. S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Beecher, C. W., Fong, H. H., Kinghorn, A. D. and Brown, D. M. : Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 10, 1046 (1995)
  2. Liu, W. K., Ho, J. C., Cheung, F. W., Liu, B. P., Ye, W. C. and Che, C. T. : Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line. Eur. J. Pharmacol. 498, 71 (2004)
  3. Fulda, S., Jeremias, I., Steiner, H. H., Pietsch, T. and Debatin, K. M. : Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int. J. Cancer. 82, 435 (1999)
  4. Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E. and Debatin, K. M. : Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem. 273, 33942 (1998)
  5. Fulda, S. and Debatin, K. M. : Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med. Pediatr. Oncol. 35, 616 (2000)
  6. Wick, W., Grimmel, C., Wagenknecht, B., Dichgans, J. and Weller, M. : Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. J. Pharmacol. Exp. Ther. 289, 1306 (1999)
  7. Schuhly, W., Heilmann, J., Calis, I. and Sticher, O. : New triterpenoids with antibacterial activity from Zizyphus joazeiro. Planta Med. 65, 740 (1999)
  8. Steele, J. C., Warhurst, D. C., Kirby, C. C. and Simmonds, M. S. : In vitro and in vivo evaluation of betulinic acid as an antimalarial. Phytother. Res. 13, 115 (1999)
  9. Bringmann, G., Saeb, W., Assi, L. A., Francois, G., Sankara Narayanan, A. S., Peters, K. and Peters, E. M. : Betulinic acid: isolation from Triphyophyllum peltatum and Ancistrocladus heyneanus, antimalarial activity, and crystal structure of the benzyl ester. Planta Med. 63, 255 (1997)
  10. Honda, T., Liby, K. T., Su, X., Sundararajan, C., Honda, Y., Suh, N., Risingsong, R., Williams, C. R., Royce, D. B., Sporn, M. B. and Gribble, G. W. : Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A. Bioor. Med. Chem. Lett. 16, 6306 (2006)
  11. Zhou, J., Huang, L., Hachey, D. L., Chen, C. H. and Aiken, C. : Inhibition of HIV-1 maturation via drug association with the viral Gag protein in immature HIV-1 particles. J. Biol. Chem. 280, 42149 (2005)
  12. Aiken, C. and Chen, C. H. : Betulinic acid derivatives as HIV-1 antivirals. Trends Mol. Med. 11, 31 (2005)
  13. Robinson, E. A., Yoshimura, T., Leonard, E. J., Tanaka, S., Griffin, P. R., Shabanowitz, J., Hunt, D. F. and Appella, E. : Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. Proc. Natl. Acad. Sci. USA 86, 1850 (1989)
  14. Folkard, S. G., Westwick, J. and Millar, A. B. : Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur. Respir. J. 10, 2097 (1997)
  15. Sousa, A. R., Lane, S. J., Nakhosteen, J. A., Yoshimura, T., Lee, T. H. and Poston, R. N. : Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 10, 42 (1994)
  16. Gu, L., Okada, Y., Linton, S. K., Gerard, C., Sukhova, G. K., Libby, P. and Rollins, B. J. : Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275 (1998)
  17. Reape, T. J. and Groot, P. H. : Chemokines and atherosclerosis. Atherosclerosis 147, 213 (1999)
  18. Yun, Y., Han, S., Park, E., Yim, D., Lee, S., Lee, C. K., Cho, K. and Kim, K. : Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages. Arch. Pharm. Res. 26, 1087 (2003)